Gaskiyar cewa a nan gaba Oncology zai daina zama jumla, masana kimiyya sun sake fara magana. Bugu da ƙari, sabon binciken da masu bincike daga Jami’ar Notre Dame (South Bend, Amurka) suka yi ya nuna cewa ana iya samun ci gaba ta gaske har ma a magance nau’o’in cutar daji mafi haɗari, waɗanda ke da tsauri ga magungunan da ake da su.
Sanarwar manema labarai da aka buga akan gidan yanar gizon Medical Xpress ya tattauna takamaiman kaddarorin enzyme na furotin RIPK1. Yana daya daga cikin masu shiga cikin tsarin necrosis na cell. Duk da haka, kamar yadda masana kimiyya suka gano, wannan sunadaran kuma zai iya toshe ci gaban mummunan neoplasms da faruwar metastases. A sakamakon haka, wannan fili na iya zama ɗaya daga cikin abubuwan da ke tattare da magungunan da ake nufi don maganin cututtukan daji mafi haɗari.
Kamar yadda aka sani a sakamakon binciken, RIPK1 yana taimakawa wajen rage kasancewar mitochondria a cikin sel. Waɗannan su ne gabobin da ke da alhakin aiwatar da musayar makamashi. Lokacin da adadin su ya ragu, abin da ake kira "danniya oxidative" ya fara tasowa. Yawancin nau'in oxygen mai amsawa yana lalata sunadarai, DNA da lipids, sakamakon abin da tsarin lalata kansa ya fara. A wasu kalmomi, an fara aiwatar da ko dai necrosis ko cell apoptosis.
Masana kimiyya suna tunatar da cewa necrosis wani tsari ne na pathological wanda kwayar halitta kanta ta lalace, kuma sakin abinda ke ciki yana faruwa a cikin sararin samaniya. Idan tantanin halitta ya mutu bisa ga tsarin halittarsa, wanda ake kira apoptosis, to ana cire ragowar ta daga nama, wanda ke kawar da yiwuwar kumburi.
A cewar masu bincike na Amurka, RIPK1 na iya zama ɗaya daga cikin abubuwan da ke haifar da abin da ake kira "mutuwar kwayar halitta". A wasu kalmomi, ana iya amfani da shi azaman makamin "lalacewar maki" - don amfani da "yajin" da aka yi niyya ga ƙwayar cuta tare da enzyme mai gina jiki. Wannan zai taimaka dakatar da aiwatar da metastasis da karuwa a cikin neoplasm.